U.S. flag An official website of the United States government.
Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Advisory Committee on Immunization Practices (ACIP)

CDC Stacks Public Health Publications

The ACIP is a group of medical and public health experts that develops recommendations on the use of vaccines in the civilian population of the United States. The ACIP holds three meetings each year at the Centers for Disease Control and Prevention (CDC), in Atlanta, Georgia to make vaccine recommendations. Meetings are open to the public and available online via webcast. More information on ACIP is available at: https://www.cdc.gov/vaccines/acip/index.html.

(93)
(134)
(234)
(272)
(175)
(108)
(133)
(111)
(96)
(79)
(115)
(115)
(125)
(16)
(23)
(16)
(18)
(13)
(17)
(9)
(8)
(15)
(11)
(6)
(10)
(10)
(5)
(10)
(11)
(5)
(8)
(9)
(6)
(9)
(8)
(7)
(6)
(10)
(5)
(6)
(5)
(6)
(6)
(5)
(5)
(6)
(9)
(3)
(8)
(4)
(3)
(2)
(5)
(3)
(2)
(4)
(3)
(3)
(2)
(2)
(1)
0 of 61
(12)
(32)
(108)
(35)
(11)
(1)
(1)
(48)
(48)
(49)
(7)
(1293)
(463)
(7)
0 of 14
(1)
(1)
(1)
(4)
(2)
(1)
(1)
(2)
(6)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(6)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(406)
(1)
(1)
(1)
(1)
(1)
(1)
0 of 46
(1)
(1)
(1)
0 of 3
(10)
(5)
(1)
(4)
(2)
(3)
(1)
(5)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(126)
(1)
(146)
(1)
(33)
(66)
(1)
(1)
(62)
(14)
(2)
(3)
(18)
(1)
(4)
(1)
(1)
(1)
(2)
(31)
(2)
(3)
(1)
(1)
(3)
(6)
(1)
(1)
(10)
(1)
(3)
(2)
(2)
(14)
(2)
(2)
(3)
(5)
(2)
(1)
(9)
(3)
(1)
(2)
(2)
(4)
(1)
(1)
(1)
(1)
(5)
(3)
(1)
(7)
(1)
(10)
(1)
(1)
(10)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(7)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(3)
(1)
(9)
(1)
(1)
(1)
(12)
(1)
(2)
(1)
(3)
(9)
(1)
(6)
(1)
(3)
(10)
(1)
(1)
(1)
(1)
(1)
(2)
(3)
(3)
(1)
(11)
(2)
(2)
(4)
(1)
(3)
(13)
(8)
(153)
(106)
(2)
(2)
(1)
(1)
(11)
(2)
(1)
(10)
(2)
(7)
(2)
(1)
(1)
(1)
(7)
(15)
(4)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(20)
(5)
(197)
(44)
(5)
(4)
(1)
(19)
(2)
(2)
(82)
(2)
(257)
(6)
(21)
(2)
(1)
(3)
(1)
(1)
(8)
(1)
(4)
(2)
(1)
(1)
(117)
(7)
(5)
(3)
(1)
(1)
(1)
(3)
(1)
(1)
(3)
(35)
(2)
(1)
(16)
(2)
(12)
(1)
(32)
(2)
(2)
(1)
(1)
(1)
(3)
(22)
(1)
(2)
(2)
(10)
(2)
(2)
(2)
(3)
(1)
(1)
(2)
(23)
(10)
(3)
(5)
(1)
(1)
(15)
(1)
(3)
(1)
(9)
(1)
(2)
(2)
(1)
(1)
(2)
(2)
(1)
(4)
(1)
(1)
(17)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(3)
(2)
(1)
(2)
(1)
(5)
(1)
(1)
(2)
(2)
(1)
(4)
(1)
(9)
(2)
(5)
(1)
(1)
(1)
(1)
(1)
(1)
(51)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(21)
(3)
(1)
(5)
(1)
(15)
(1)
(56)
(1)
(2)
(5)
(2)
(2)
(1)
(1)
(3)
(5)
(2)
(1)
(15)
(1)
(1)
(2)
(2)
(1)
(3)
(1)
(33)
(2)
(1)
(3)
(2)
(2)
(1)
(19)
(2)
(2)
(4)
(4)
(2)
(1)
(1)
(2)
(5)
(5)
(1)
(1)
(1)
(7)
(9)
(9)
(1)
(1)
(3)
(1)
(26)
(3)
(1)
(2)
(1)
(1)
(10)
(1)
(2)
(1)
(1)
(39)
(2)
(1)
(1)
(1)
(3)
(4)
(1)
(2)
(3)
(1)
(35)
(1)
(1)
(1)
(7)
(1)
(6)
(2)
(10)
(11)
(1)
(1)
(6)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(165)
(5)
(1)
(1)
(4)
(343)
(1)
(6)
(3)
(76)
(2)
(2)
(1)
(1)
(1)
(2)
(50)
(6)
(4)
(321)
(1)
(1)
(1)
(192)
(1)
(2)
(17)
(3)
(2)
(3)
(3)
(1)
(1)
(1)
(1)
(6)
(6)
(104)
(1)
(69)
(1)
(5)
(2)
(3)
(2)
(1)
(1)
(39)
(1)
(1)
(10)
(1)
(11)
(4)
(25)
(15)
(2)
(1)
(2)
(1)
(3)
(10)
(4)
(15)
(2)
(13)
(2)
(18)
(6)
(2)
(1)
(1)
(2)
(2)
(4)
(172)
(18)
(2)
(1)
(11)
(5)
(2)
(2)
(2)
(1)
(1)
(1)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(3)
(1)
(1)
(1)
(1)
(12)
(3)
(2)
(4)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(10)
(1)
(4)
(1)
(1)
(31)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(3)
(2)
(6)
(1)
(13)
(2)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(40)
(1)
(2)
(8)
(1)
(11)
(1)
(1)
(6)
(28)
(1)
(1)
(1)
(2)
(1)
(7)
(1)
(9)
(1)
(1)
(1)
(2)
(1)
(2)
(4)
(1)
(1)
(3)
(14)
(3)
(1)
(10)
(2)
(1)
(104)
(1)
(1)
(1)
(1)
(1)
(1)
(61)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(10)
(1)
(3)
(4)
(14)
(1)
(12)
(3)
(4)
(3)
(1)
(6)
(1)
(7)
(1)
(1)
(5)
(1)
(13)
(2)
(1)
(1)
(1)
(1)
(1)
(5)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(4)
(1)
(7)
(1)
(3)
(6)
(2)
(1)
(2)
(1)
(2)
(1)
(7)
(1)
(1)
(1)
(2)
(1)
(1)
(29)
(152)
(5)
(1)
(1)
(1)
(3)
(2)
(55)
(1)
(1)
(34)
(1)
(8)
(1)
(1)
(56)
(2)
(1)
(6)
(1)
(1)
(1)
(35)
(2)
(1)
(2)
(1)
(1)
(6)
(1)
(1)
(1)
(1)
(1)
(17)
(1)
(1)
(8)
(1)
(91)
(3)
(1)
(2)
(4)
(1)
(1)
(11)
(2)
(3)
(1)
(3)
(1)
(4)
(2)
(6)
(2)
(2)
(1)
(8)
(2)
(1)
(5)
(1)
(10)
(12)
(1)
(6)
(1)
(1)
(1)
(6)
(1)
(35)
(1)
(9)
(1)
(62)
(6)
(3)
(2)
(1)
(1)
(1)
(2)
(1)
(26)
(1)
(1)
(1)
(1)
(1)
(3)
(3)
(1)
(16)
(1)
(1)
(1)
(4)
(2)
(14)
(1)
(1)
(4)
(3)
(2)
(12)
(1)
(1)
(4)
(5)
(2)
(1)
(11)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(10)
(6)
(2)
(1)
(49)
(13)
(8)
(48)
(8)
(2)
(13)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(4)
(18)
(12)
(1)
(1)
(3)
(9)
(1)
(2)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(32)
(5)
(2)
(13)
(5)
(1)
(1)
(2)
(19)
(1)
(6)
(2)
(1)
(2)
(1)
(2)
(2)
(1)
(1)
(3)
(2)
(1)
(4)
(2)
(1)
(1)
(2)
(1)
(1)
(26)
(2)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(11)
(1)
(2)
(1)
(2)
(1)
(3)
(2)
(6)
(1)
(5)
(4)
(8)
(5)
(1)
(1)
(21)
(1)
(1)
(2)
(7)
(3)
(2)
(2)
(2)
(1)
(2)
(1)
(1)
(630)
(17)
(2)
(1)
(1)
(5)
(1)
(1)
(24)
(22)
(4)
(4)
(1)
(13)
(379)
(1)
(28)
(23)
(23)
(1)
(1)
(1)
(21)
(1)
(1)
(1)
(1)
(1)
(1)
(9)
(2)
(1)
(1)
(51)
(2)
(1)
(11)
(1)
(1)
(18)
(1)
(2)
(1)
(2)
(5)
(3)
(1)
(1)
(12)
(1)
(2)
(170)
(2)
(1)
(1)
(1)
(1)
(21)
(1)
(1)
(10)
(1)
(1)
(4)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(2)
(1)
(11)
(2)
(1)
(2)
(1)
(2)
(1)
(2)
(1)
(33)
(1)
(2)
(4)
0 of 940
(1)
(1)
(1)
(3)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(3)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(7)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(7)
(1)
(9)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(39)
(2)
(1)
(8)
(16)
(1)
(4)
(4)
(2)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(4)
(2)
(1)
(1)
(3)
(23)
(1)
(1)
(8)
(2)
(1)
(11)
(1)
(1)
(1)
(15)
(1)
(1)
(14)
(1)
(1)
(5)
(1)
(2)
(1)
(1)
(3)
(8)
(21)
(1)
(1)
(9)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(16)
(2)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(10)
(1)
(1)
(2)
(7)
(1)
(1)
(5)
(1)
(8)
(2)
(5)
(10)
(2)
(1)
(1)
(2)
(2)
(2)
(22)
(3)
(4)
(4)
(4)
(3)
(1)
(22)
(1)
(7)
(1)
(4)
(2)
(2)
(4)
(4)
(2)
(32)
(2)
(1)
(1)
(1)
(6)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(1)
(31)
(3)
(1)
(5)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(1)
(2)
(1)
(7)
(1)
(4)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(4)
(2)
(2)
(3)
(1)
(7)
(1)
(2)
(1)
(1)
(10)
(10)
(1)
(11)
(2)
(6)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(9)
(4)
(2)
(1)
(1)
(1)
(5)
(8)
(1)
(2)
(1)
(5)
(7)
(1)
(1)
(1)
(3)
(2)
(2)
(1)
(12)
(1)
(2)
(5)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(2)
(1)
(51)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(2)
(1)
(1)
(4)
(2)
(1)
(15)
(1)
(4)
(8)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(7)
(1)
(3)
(3)
(1)
(4)
(4)
(1)
(1)
(3)
(5)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(14)
(20)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(2)
(12)
(1)
(1)
(1)
(1)
(9)
(1)
(8)
(1)
(1)
(1)
(1)
(1)
(2)
(8)
(1)
(1)
(1)
(2)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(7)
(1)
(11)
(1)
(2)
(2)
(1)
(1)
(1)
(13)
(1)
(1)
(1)
(1)
(6)
(1)
(1)
(7)
(2)
(1)
(1)
(1)
(4)
(3)
(1)
(1)
(1)
(1)
(11)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(7)
(21)
(1)
(2)
(1)
(3)
(7)
(3)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(15)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(34)
(2)
(1)
(2)
(8)
(3)
(1)
(1)
(1)
(1)
(2)
(1)
(15)
(1)
(1)
(1)
(5)
(1)
(13)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(7)
(1)
(9)
(1)
(1)
(1)
(1)
(1)
(1)
(7)
(1)
(14)
(9)
(1)
(1)
(1)
(2)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(3)
(11)
(1)
(37)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(8)
(1)
(1)
(1)
(4)
(2)
(10)
(1)
(8)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(5)
(3)
(2)
(2)
(1)
(1)
(4)
(6)
(8)
(1)
(6)
(1)
(2)
(1)
(3)
(5)
(2)
(4)
(2)
(5)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(5)
(1)
(11)
(2)
(1)
(3)
(1)
(4)
(2)
(1)
(12)
(2)
(2)
(6)
(1)
(1)
(9)
(2)
(1)
(2)
(1)
(7)
(7)
(1)
(1)
(2)
(1)
(11)
(8)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(3)
(54)
(2)
(4)
(4)
(1)
(1)
(2)
(1)
(3)
(1)
(1)
(6)
(9)
(3)
(1)
(1)
(1)
(1)
(2)
(2)
(3)
(1)
(1)
(4)
(1)
(3)
(1)
(1)
(6)
(3)
(2)
(2)
(1)
(1)
(1)
(4)
(7)
(2)
(4)
(1)
(8)
(1)
(1)
(25)
(1)
(1)
(10)
(17)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(6)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(14)
(4)
(3)
(2)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(18)
(1)
(2)
(1)
(1)
(7)
(1)
(2)
(10)
(1)
(1)
(1)
(1)
(30)
(2)
(2)
(2)
(1)
(1)
(1)
(1)
(2)
(3)
(2)
(1)
(3)
(1)
(2)
(1)
(19)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(8)
(1)
(30)
(5)
(1)
(11)
(3)
(1)
(1)
(2)
(1)
(2)
(2)
(8)
(1)
(1)
(1)
(1)
(1)
(7)
(4)
(2)
(1)
(4)
(2)
(1)
(2)
(1)
(4)
(1)
(1)
(1)
(1)
(2)
(1)
(8)
(2)
(1)
(1)
(2)
(45)
(1)
(1)
(7)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(10)
(1)
(1)
(1)
(10)
(1)
(1)
(13)
(1)
(8)
(7)
(1)
(2)
(1)
(8)
(8)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(7)
(8)
(2)
(1)
(32)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(10)
(1)
(1)
(1)
(2)
(1)
(3)
(5)
(4)
(1)
(2)
(2)
(1)
(1)
(9)
(2)
(2)
(10)
(1)
(1)
(1)
(2)
(1)
(5)
(1)
(1)
(4)
(2)
(2)
(26)
(1)
(1)
(24)
(1)
(1)
(1)
(3)
(1)
(1)
(2)
(4)
(5)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(5)
(4)
(2)
(2)
(1)
(1)
(11)
(3)
(1)
(4)
(1)
(1)
(5)
(1)
(2)
(9)
(1)
(1)
(6)
(2)
(1)
(3)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
0 of 899
(2)
(1)
(1)
(3)
(1)
(1)
(2)
(2)
(5)
(24)
(3)
(4)
(6)
(1)
(16)
(21)
(9)
(1)
(1)
(1)
(1)
(6)
(3)
(1)
(4)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(3)
(1)
(8)
(1)
(3)
(6)
(1)
(1)
(2)
(14)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(29)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(2)
(50)
(113)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(6)
(1)
(1)
(2)
(2)
(9)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(2)
(4)
(1)
(1)
(1)
(5)
(1)
(11)
(1)
(2)
(1)
(1)
(4)
(2)
(1)
(1)
(1)
(1)
(4)
(2)
(1)
(1)
(1)
(6)
(1)
(1)
(8)
(1)
(2)
(7)
(5)
(1)
(1)
(5)
(2)
(6)
(1)
(1)
(1)
(12)
(1)
(9)
(2)
(1)
(5)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(4)
(3)
(4)
(1)
(16)
(11)
(1)
(8)
(6)
(1)
(3)
(1)
(5)
(1)
(3)
(25)
(3)
(8)
(1)
(1)
(1)
(30)
(4)
(6)
(1)
(12)
(34)
(30)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(9)
(1)
(10)
(14)
(2)
(10)
(1)
(90)
(1)
(1)
(1)
(1)
(1)
(1)
(7)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(46)
(4)
(3)
(2)
(66)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(83)
(1)
(1)
(1)
(2)
(53)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(3)
(2)
(6)
(9)
(1)
(10)
(1)
(1)
(2)
(3)
(6)
(2)
(1)
(5)
(4)
(1)
(3)
(2)
(1)
(1)
(13)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(10)
(1)
(22)
(3)
(7)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(4)
(1)
(1)
(1)
(4)
(9)
(1)
(2)
(1)
(1)
(1)
(3)
(1)
(2)
(3)
(3)
(1)
(2)
(10)
(1)
(6)
(1)
(1)
(11)
(1)
(1)
(1)
(1)
(3)
(1)
(7)
(1)
(1)
(1)
(1)
(1)
(13)
(1)
(14)
(547)
(1)
(1)
(1)
(6)
(1)
(3)
(1)
(4)
(10)
(1)
(15)
(11)
(14)
(1)
(4)
(4)
(1)
(2)
(2)
(5)
(1)
(4)
(1)
(162)
(1)
(5)
(1)
(3)
(7)
(3)
(1)
(33)
(2)
(14)
(3)
(3)
(9)
(2)
(1)
(10)
(1)
(2)
(30)
(6)
(1)
(4)
(4)
(5)
(2)
(7)
(1)
(6)
(2)
(1)
(19)
(15)
(1)
(1)
(9)
(5)
(1)
(2)
(2)
(18)
(3)
(5)
(46)
(2)
(1)
(2)
(3)
(2)
(1)
(3)
(4)
(1)
(5)
(1)
(1)
(4)
(3)
(1)
(1)
(7)
(2)
(2)
(3)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(3)
(7)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(10)
(3)
(2)
(3)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(11)
(1)
(1)
(1)
(3)
(1)
(2)
(1)
0 of 464
(1)
(74)
(1)
(1)
(1624)
(32)
(7)
(8)
(1)
(14)
(102)
(200)
(10)
(12)
(32)
(1295)
(1)
(18)
(2)
(2)
(38)
(1)
(1)
(1)
0 of 24
(1)
(1)
(1)
(1)
(1)
(1)
0 of 6
(1)
0 of 1
Showing 1461 - 1480 of 2154 results
  • Timing and spacing of immunobiologics febrile seizures and simultaneous vaccination
    Timing and spacing of immunobiologics : febrile seizures and simultaneous vaccination
    Kroger, Andrew T.
    October 29, 2014 | ACIP: General Recommendations
    No Description
    Public Domain
  • Update on effectiveness of liveattenuated versus inactivated influenza vaccines in children and adolescents aged 218 years US Flu VE Network
    Update on effectiveness of live-attenuated versus inactivated influenza vaccines in children and adolescents aged 2–18 years – US Flu VE Network
    Flannery, Brendan
    October 29, 2014 | ACIP: Influenza
    No Description
    Public Domain
  • Vaccine supply update
    Vaccine supply update
    Santoli, Jeanne M.
    October 29, 2014 | ACIP: Vaccine Supply
    No Description
    Public Domain
  • History and Evolution of the Advisory Committee on Immunization PracticesUnited States 19642014
    History and Evolution of the Advisory Committee on Immunization Practices--United States, 1964-2014
    Smith, Jean Clare ;
    Hinman, Alan R.
    October 24, 2014 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    The Advisory Committee on Immunization Practices (ACIP) is chartered as a federal advisory committee to provide expert external advice to CDC and the Secretary of the U.S. Department of Health and Human Services (DHHS) on the use of vaccines in the civilian population of the United States. This report summarizes the evolution of ACIP over the 50 ye ...
    Supporting Files Public Domain
  • Agenda Meeting of the Advisory Committee on Immunization Practices October 2930 2014
    [Agenda] : Meeting of the Advisory Committee on Immunization Practices, October 29-30, 2014
    United States. Advisory Committee on Immunization Practices.
    October 22, 2014 | ACIP: Meeting Agenda, Minutes, etc.
    FINAL - October 22, 2014agenda-archive/agenda-2014-10.pdf
    Public Domain
  • Advisory Committee on Immunization Practices ACIP summary report August 13 2014 Atlanta Georgia
    Advisory Committee on Immunization Practices (ACIP) summary report : August 13, 2014, Atlanta, Georgia
    United States. Advisory Committee on Immunization Practices.
    10/20/2014 | ACIP: Meeting Agenda, Minutes, etc.
    No Description
    Public Domain
  • Use of 13Valent Pneumococcal Conjugate Vaccine and 23Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged 65 Years Recommendations of the Advisory Committee on Immunization Practices ACIP
    Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
    Tomczyk, Sara ;
    Bennett, Nancy M.
    Sep 19 2014 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    On August 13, 2014, the Advisory Committee on Immunization Practices (ACIP) recommended routine use of 13-valent pneumococcal conjugate vaccine (PCV13 [Prevnar 13, Wyeth Pharmaceuticals, Inc., a subsidiary of Pfizer Inc.]) among adults aged ≥65 years. PCV13 should be administered in series with the 23-valent pneumococcal polysaccharide vaccine (PPS ...
    Supporting Files Public Domain
  • 2014 recommended immunizations for adults by age
    2014 recommended immunizations for adults by age
    National Center for Immunization and Respiratory Diseases (U.S.)  ...
    September 18, 2014
    This easy-to-read schedule was updated September 18, 2014 to reflect the latest pneumococcal vaccination recommendations from the Advisory Committee on Immunization Practices. www.cdc.gov/vaccines/vpd-vac/pneumoCS251118
    Current Public Domain
  • Morbidity and Mortality Weekly Report MMWR Recommendations and Reports Vol 63 No 5 August 29 2014
    Morbidity and Mortality Weekly Report (MMWR): Recommendations and Reports / Vol. 63 / No. 5, August 29, 2014
    Markowitz, Lauri E. ;
    Dunne, Eileen F.
    August 29, 2014 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
    This report summarizes the epidemiology of human papillomavirus (HPV) and associated diseases, describes the licensed HPV vaccines, provides updated data from clinical trials and post licensure safety studies, and compiles recommendations from CDC's Advisory Committee on Immunization Practices (ACIP) for use of HPV vaccines. Persistent infection wi ...
    Current Public Domain
  • Update on Recommendations for Use of Herpes Zoster Vaccine
    Update on Recommendations for Use of Herpes Zoster Vaccine
    Hales, Craig M. ;
    Harpaz, Rafael
    August 22, 2014 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Herpes zoster vaccine (Zostavax [Merck & Co., Inc.]) was licensed in 2006 and recommended by the Advisory Committee on Immunization Practices (ACIP) in 2008 for prevention of herpes zoster (shingles) and its complications among adults aged ≥60 years. The Food and Drug Administration (FDA) approved the use of Zostavax in 2011 for adults aged 50 thro ...
    Current Public Domain
  • Update on Recommendations for Use of Herpes Zoster Vaccine
    Update on Recommendations for Use of Herpes Zoster Vaccine
    Hales, Craig M. ;
    Harpaz, Rafael
    Aug 22 2014 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Herpes zoster vaccine (Zostavax [Merck & Co., Inc.]) was licensed in 2006 and recommended by the Advisory Committee on Immunization Practices (ACIP) in 2008 for prevention of herpes zoster (shingles) and its complications among adults aged ≥60 years. The Food and Drug Administration (FDA) approved the use of Zostavax in 2011 for adults aged 50 thro ...
    Supporting Files Public Domain
  • Prevention and control of seasonal influenza with vaccines recommendations of the Advisory Committee on Immunization Practices ACIP United States 201415 influenza season
    Prevention and control of seasonal influenza with vaccines : recommendations of the Advisory Committee on Immunization Practices (ACIP) -- United States, 2014-15 influenza season
    Grohskopf, Lisa A. ;
    Olson, Sonja J.
    August 15, 2014 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    This report updates the 2013 recommendations by the Advisory Committee on Immunization Practices (ACIP) regarding use of seasonal influenza vaccines. Updated information for the 2014-15 influenza season includes 1) antigenic composition of U.S. seasonal influenza vaccines; 2) vaccine dose considerations for children aged 6 months through 8 years; a ...
    Superseded Public Domain
  • Prevention and Control of Seasonal Influenza with Vaccines Recommendations of the Advisory Committee on Immunization Practices ACIP United States 201415 Influenza Season
    Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP) — United States, 2014–15 Influenza Season
    Grohskopf, Lisa A. ;
    Olsen, Sonja J.
    Aug 15 2014 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    This report updates the 2013 recommendations by the Advisory Committee on Immunization Practices (ACIP) regarding use of seasonal influenza vaccines. Updated information for the 2014-15 influenza season includes 1) antigenic composition of U.S. seasonal influenza vaccines; 2) vaccine dose considerations for children aged 6 months through 8 years; a ...
    Supporting Files Public Domain
  • 13valent pneumococcal conjugate vaccine
    13-valent pneumococcal conjugate vaccine
    Bennett, Nancy M.
    August 13, 2014 | ACIP: Pneumococcal
    No Description
    Public Domain
  • Considerations for pneumococcal 13valent conjugate and 23valent polysaccharide vaccine use among adults
    Considerations for pneumococcal 13-valent conjugate and 23-valent polysaccharide vaccine use among adults
    Pilishvili, Tamara
    August 13, 2014 | ACIP: Pneumococcal
    No Description
    Public Domain
  • Agenda Meeting of the Advisory Committee on Immunization Practices August 13 2014
    [Agenda] : Meeting of the Advisory Committee on Immunization Practices, August 13, 2014
    United States. Advisory Committee on Immunization Practices.
    July 28, 2014 | ACIP: Meeting Agenda, Minutes, etc.
    Final – July 28, 2014agenda-2014-08.pdf
    Public Domain
  • Considerations for agebased recommendations for pneumococcal conjugate vaccine for adults
    Considerations for age-based recommendations for pneumococcal conjugate vaccine for adults
    Pilishvili, Tamara
    June 26, 2014 | ACIP: Pneumococcal
    No Description
    Public Domain
  • 13valent pneumococcal conjugate vaccine
    13-valent pneumococcal conjugate vaccine
    Bennett, Nancy M.
    06/26/2014 | ACIP: Pneumococcal
    No Description
    Public Domain
  • Agenda Meeting of the Advisory Committee on Immunization Practices June 2526 2014
    [Agenda] : Meeting of the Advisory Committee on Immunization Practices, June 25-26, 2014
    United States. Advisory Committee on Immunization Practices.
    June 26, 2014 | ACIP: Meeting Agenda, Minutes, etc.
    Final – June 26, 2014agenda-2014-06.pdf
    Public Domain
  • ACIP typhoid fever vaccine update
    ACIP typhoid fever vaccine update
    Jackson, Brendan R.
    June 26, 2014 | ACIP: Typhoid
    No Description
    Public Domain
1461 - 1480 / 2154